<DOC>
	<DOCNO>NCT00134342</DOCNO>
	<brief_summary>The tuberculin skin test ( TST ) gold standard diagnose latent tuberculosis almost 100 year . While test performs reasonably well healthy , non-bacille Calmette-Guerin ( BCG ) vaccinate population , believe perform le well patient intact cellular immune system ( immunocompromised ) . The investigator hypothesize new test , T-SPOT TB ELISPOT test provide accurate measurement latent infection immunocompromised people . This study compare TST T-SPOT TB ELISPOT test , result expert physician diagnostic panel .</brief_summary>
	<brief_title>Tuberculosis ( TB ) Screening Diagnosis Latent TB Immunocompromised Populations</brief_title>
	<detailed_description>Main Study Question : We propose investigate correlation traditional TST-based method screen latent tuberculosis infection specific immunocompromised population recommend Canadian American standard : T-SPOT TB ELISPOT test : expert tuberculosis physician panel incorporate Mantoux test , risk factor survey , chest radiograph . Secondary Study Question : In subset patient test positive Mantoux T-SPOT ELISPOT test prior undergoing additional immune suppression i.e. , patient pre-bone marrow transplant rheumatology patient pre-receipt anti-TNF alpha therapy high dose corticosteroid , propose repeat T-SPOT ELISPOT Mantoux immune suppression ass development cutaneous anergy .</detailed_description>
	<mesh_term>Tuberculosis</mesh_term>
	<mesh_term>Latent Tuberculosis</mesh_term>
	<criteria>Inclusion criterion study broad . Participants enrol regardless race , gender , risk exposure TB , metabolic disorder coinfection nonTB agent . Only participants provide write informed consent include . Patients belong four follow group consider eligible tuberculosis screen inclusion TSPOT ELISPOT study : Patients end stage renal disease receive hemodialysis peritoneal dialysis ; Recipients solid organ transplant ; Recipients , candidate , allogeneic stem cell transplant hematologic malignancy ; Patients rheumatologic disease ( e.g. , systemic lupus erythematosus [ SLE ] , rheumatoid arthritis , psoriasis ) receiving , receive , immunosuppressive therapy , include corticosteroid antiTNF alpha inhibitor . Individuals sign informed consent Hemophiliacs individual , advice enrol physician , may otherwise increase risk adverse reaction venipuncture tuberculin skin test administration</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2005</verification_date>
	<keyword>tuberculosis</keyword>
	<keyword>tuberculin test</keyword>
	<keyword>immunologic test</keyword>
	<keyword>Latent tuberculosis</keyword>
	<keyword>end stage renal disease</keyword>
	<keyword>solid organ transplantation</keyword>
	<keyword>bone marrow transplantation</keyword>
	<keyword>rheumatologic disease</keyword>
</DOC>